| scholarly article | Q13442814 |
| P50 | author | Wim Oyen | Q42976851 |
| Otto C. Boerman | Q57233096 | ||
| Peter Laverman | Q75070499 | ||
| P2093 | author name string | David M Goldenberg | |
| Robert M Sharkey | |||
| William J McBride | |||
| Annemarie Eek | |||
| Wim J G Oyen | |||
| Lieke Joosten | |||
| P2860 | cites work | Ternary hydroxide complexes in neutral solutions of Al3+ and F-. | Q30461858 |
| "Click labeling" with 2-[18f]fluoroethylazide for positron emission tomography. | Q30831041 | ||
| Click chemistry for (18)F-labeling of RGD peptides and microPET imaging of tumor integrin alphavbeta3 expression | Q34282895 | ||
| A novel method for direct site-specific radiolabeling of peptides using [18F]FDG. | Q34947836 | ||
| In vivo positron emission tomography (PET) imaging with an alphavbeta6 specific peptide radiolabeled using 18F-"click" chemistry: evaluation and comparison with the corresponding 4-[18F]fluorobenzoyl- and 2-[18F]fluoropropionyl-peptides | Q39941022 | ||
| Influence of different spacers on the biological profile of a DOTA-somatostatin analogue. | Q40182690 | ||
| First (18)F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using positron emission tomography | Q40550081 | ||
| PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide. | Q44250204 | ||
| Synthesis, 18F-labeling, and in vitro and in vivo studies of bombesin peptides modified with silicon-based building blocks. | Q44713796 | ||
| Two-step methodology for high-yield routine radiohalogenation of peptides: (18)F-labeled RGD and octreotide analogs | Q44891219 | ||
| A novel method of 18F radiolabeling for PET. | Q46011404 | ||
| (18)F-Fluoroglucosylation of peptides, exemplified on cyclo(RGDfK). | Q46059201 | ||
| Convenient preparation of 68Ga-based PET-radiopharmaceuticals at room temperature | Q46801081 | ||
| Spatial resolution and sensitivity of the Inveon small-animal PET scanner. | Q51856588 | ||
| PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation. | Q53467881 | ||
| One-step synthesis of 18F labeled [18F]-N-succinimidyl 4-(fluoromethyl)benzoate for protein labeling | Q72640088 | ||
| (2-[18F]fluoropropionyl-(D)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: synthesis, radiolabeling, in vitro validation and biodistribution in mice | Q73537171 | ||
| Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use | Q73697718 | ||
| Silicon-based building blocks for one-step 18F-radiolabeling of peptides for PET imaging | Q81321213 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluorine | Q650 |
| P304 | page(s) | 454-461 | |
| P577 | publication date | 2010-02-11 | |
| P1433 | published in | The Journal of Nuclear Medicine | Q7743608 |
| P1476 | title | A novel facile method of labeling octreotide with (18)F-fluorine | |
| P478 | volume | 51 |
| Q49797952 | 18F-AlF Labeled Peptide and Protein Conjugates as Positron Emission Tomography (PET) Imaging Pharmaceuticals. |
| Q89030232 | 18F-AlF-Labeled Biomolecule Conjugates as Imaging Pharmaceuticals |
| Q27023393 | 18F-Labeled Peptides: The Future Is Bright |
| Q38262524 | 18F-labelled intermediates for radiosynthesis by modular build-up reactions: newer developments |
| Q93185860 | 18F[AlF]-radiolabelled Peptides on the Automated Synthesis Platform: Translating the Laboratory Bench Work to Bedside |
| Q92503500 | A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling? |
| Q39066397 | A comparative study of radiolabeled bombesin analogs for the PET imaging of prostate cancer |
| Q82262571 | A critical study on borosilicate glassware and silica-based QMA’s in nucleophilic substitution with [18F]fluoride: influence of aluminum, boron and silicon on the reactivity of [18F]fluoride |
| Q38177202 | Al(18) F labeling of peptides and proteins |
| Q37661149 | Al18F-NODA-butyric acid: biological evaluation of a new PET renal radiotracer |
| Q58581176 | AlF-NODA Benzothiazole Derivatives as Imaging Agents for Cerebrovascular Amyloid in Cerebral Amyloid Angiopathy |
| Q37025651 | Assessment of an elastin binding molecule for PET imaging of atherosclerotic plaques |
| Q93042382 | Automated GMP compliant production of [18F]AlF-NOTA-octreotide |
| Q37594430 | Biocompatible inorganic nanoparticles for [18F]-fluoride binding with applications in PET imaging. |
| Q38237969 | Boron-(18) F containing positron emission tomography radiotracers: advances and opportunities |
| Q34446069 | Comparison of two site-specifically (18)F-labeled affibodies for PET imaging of EGFR positive tumors |
| Q35629161 | Comparison study of [18F]FAl-NOTA-PRGD2, [18F]FPPRGD2, and [68Ga]Ga-NOTA-PRGD2 for PET imaging of U87MG tumors in mice |
| Q38217835 | Current molecular imaging positron emitting radiotracers in oncology |
| Q35833401 | Development of a Novel PET Tracer [18F]AlF-NOTA-C6 Targeting MMP2 for Tumor Imaging |
| Q91705461 | Direct fluorine-18 labeling of heat-sensitive biomolecules for positron emission tomography imaging using the Al18F-RESCA method |
| Q34362306 | Direct one-step labeling of cysteine residues on peptides with [(11)C]methyl triflate for the synthesis of PET radiopharmaceuticals |
| Q35237365 | Effect of co-ligands on chemical and biological properties of (99m)Tc(III) complexes [(99m)Tc(L)(CDO)(CDOH)2BMe] (L=Cl, F, SCN and N3; CDOH2=cyclohexanedione dioxime). |
| Q39144300 | Efficient bioconjugation of 5-fluoro-5-deoxy-ribose (FDR) to RGD peptides for positron emission tomography (PET) imaging of α(v)β(3) integrin receptor. |
| Q42931069 | Enhanced aqueous Suzuki-Miyaura coupling allows site-specific polypeptide 18F-labeling |
| Q34442512 | First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts |
| Q35013514 | Fluorine-18 radiochemistry, labeling strategies and synthetic routes |
| Q35228332 | High-yielding aqueous 18F-labeling of peptides via Al18F chelation |
| Q52947575 | Hydrothermal synthesis of Group 13 metal trifluoride complexes with neutral N-donor ligands. |
| Q33668360 | Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide |
| Q34033063 | Improved 18F labeling of peptides with a fluoride-aluminum-chelate complex |
| Q92134199 | Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy |
| Q47127214 | Micromolar affinity CAR T cells to ICAM-1 achieves rapid tumor elimination while avoiding systemic toxicity |
| Q38798872 | Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions. |
| Q38748846 | Molecular imaging probes derived from natural peptides. |
| Q35846622 | New lyophilized kit for rapid radiofluorination of peptides |
| Q34435482 | One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging |
| Q42876685 | Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7–14)NH2], in a prostate tumor xenografted mouse model |
| Q35810016 | Optimized labeling of NOTA-conjugated octreotide with F-18. |
| Q39004440 | PET imaging of prostate tumors with 18F-Al-NOTA-MATBBN. |
| Q28716029 | Positron emission tomography (PET) imaging with (18)F-based radiotracers |
| Q46961556 | Preparation of 18F-labeled peptides using the copper(I)-catalyzed azide-alkyne 1,3-dipolar cycloaddition |
| Q35819169 | Pretargeted immuno-PET of CEA-expressing intraperitoneal human colonic tumor xenografts: a new sensitive detection method |
| Q38022016 | Pretargeted molecular imaging and radioimmunotherapy |
| Q38842687 | Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker |
| Q39018543 | Radiofluorination of PSMA-HBED via Al(18)F(2+) Chelation and Biological Evaluations In Vitro |
| Q30887702 | Radiofluorination of a pre-formed gallium(III) aza-macrocyclic complex: towards next-generation positron emission tomography (PET) imaging agents |
| Q36880744 | Radiofluorination using aluminum-fluoride (Al18F) |
| Q26801806 | Radiolabeled Cyclic RGD Peptide Bioconjugates as Radiotracers Targeting Multiple Integrins |
| Q92442221 | Radiolabeled PET/MRI Nanoparticles for Tumor Imaging |
| Q28072021 | Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging |
| Q38008839 | Radionuclide therapy via SSTR: future aspects from experimental animal studies |
| Q37990399 | Radiopharmaceutical development of radiolabelled peptides |
| Q102369571 | Radiosynthesis of [18F]SiFAlin-TATE for clinical neuroendocrine tumor positron emission tomography |
| Q64465872 | Rapid Aqueous Late-Stage Radiolabelling of [GaF (BnMe -tacn)] by F/ F Isotopic Exchange: Towards New PET Imaging Probes |
| Q34687537 | Rapid and simple one-step F-18 labeling of peptides |
| Q46094970 | Robust surface coating for a fast, facile fluorine-18 labeling of iron oxide nanoparticles for PET/MR dual-modality imaging |
| Q95360903 | Somatostatin receptor PET ligands - the next generation for clinical practice |
| Q34473713 | Stability analysis of glutamic acid linked peptides coupled to NOTA through different chemical linkages |
| Q35287836 | Stability and in vivo behavior of Rh[16aneS4-diol]211 at complex: a potential precursor for astatine radiopharmaceuticals |
| Q52984572 | Syntheses and preliminary evaluation of [(18) F]AlF-NOTA-G-TMTP1 for PET imaging of high aggressive hepatocellular carcinoma. |
| Q64238307 | The Search for an Alternative to [Ga]Ga-DOTA-TATE in Neuroendocrine Tumor Theranostics: Current State of F-labeled Somatostatin Analog Development |
| Q35549498 | The radiolabeling of proteins by the [18F]AlF method |
| Q38628055 | [(18)F]-Group 13 fluoride derivatives as radiotracers for positron emission tomography. |
| Q47916689 | [AlCl3(BnMe2-tacn)] - a new metal chelate scaffold for radiofluorination by Cl/F exchange |
| Q38243336 | ¹⁸F-labeled silicon-based fluoride acceptors: potential opportunities for novel positron emitting radiopharmaceuticals. |
Search more.